NEOL Insider Trading Activity and SEC Form 4 Filings
NEOL insider trading summary
No open-market insider purchases or sales of Neopharm Inc (NEOL) have been reported on SEC Form 4 in the past 12 months.
Latest NEOL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 5, 2008 | John N Kapoor | Chairman of the Board | Buy | $10K (11,500 @ $0.83) |
| Jun 4, 2008 | John N Kapoor | Chairman of the Board | Buy | $18K (25,000 @ $0.72) |
| Jun 3, 2008 | John N Kapoor | Chairman of the Board | Buy | $14K (20,000 @ $0.69) |
| Jun 2, 2008 | Shahid Ali | Executive Vice President | Buy | $3K (5,000 @ $0.62) |
| Jun 2, 2008 | John N Kapoor | Chairman of the Board | Buy | $19K (28,500 @ $0.67) |
| May 30, 2008 | John N Kapoor | Chairman of the Board | Buy | $6K (9,600 @ $0.61) |
| May 30, 2008 | Bernard A Fox | Director | Buy | $2K (4,000 @ $0.61) |
| May 29, 2008 | John N Kapoor | Chairman of the Board | Buy | $234 (400 @ $0.58) |
| May 28, 2008 | John N Kapoor | Chairman of the Board | Buy | $18K (30,000 @ $0.59) |
| May 27, 2008 | Laurence Birch | President, CEO and CFO | Buy | $5K (9,000 @ $0.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.